Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
5.90
17.81
301.86%
Share Warrants & Outstandings
Total Reserve
0.95
50.17
-49.22
-98.11%
Shareholder's Funds
24.65
56.08
-31.43
-56.04%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.49
-0.49
-100.00%
Other Long Term Liabilities
0.00
1.18
-1.18
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.17
-0.17
-100.00%
Total Non-Current Liabilities
0.00
1.85
-1.85
-100.00%
Current Liabilities
Trade Payables
0.00
6.26
-6.26
-100.00%
Other Current Liabilities
0.14
5.80
-5.66
-97.59%
Short Term Borrowings
0.44
0.30
0.14
46.67%
Short Term Provisions
0.00
1.11
-1.11
-100.00%
Total Current Liabilities
0.57
13.47
-12.90
-95.77%
Total Liabilities
25.23
71.40
-46.17
-64.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
44.02
-43.97
-99.89%
Less: Accumulated Depreciation
0.01
16.06
-16.05
-99.94%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
27.96
-27.92
-99.86%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.04
-0.04
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
22.59
-22.59
-100.00%
Long Term Loans & Advances
0.02
0.87
-0.85
-97.70%
Other Non Current Assets
0.00
2.46
-2.46
-100.00%
Total Non-Current Assets
0.07
55.34
-55.27
-99.87%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
7.81
-7.81
-100.00%
Sundry Debtors
0.60
5.26
-4.66
-88.59%
Cash and Bank
21.30
0.04
21.26
53,150.00%
Other Current Assets
0.00
1.04
-1.04
-100.00%
Short Term Loans and Advances
3.26
1.90
1.36
71.58%
Total Current Assets
25.16
16.06
9.10
56.66%
Net Current Assets (Including Current Investments)
24.59
2.59
22.00
849.42%
Total Current Assets Excluding Current Investments
25.16
16.06
9.10
56.66%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
71.40
-46.17
-64.66%
Contingent Liabilities
0.49
2.25
-1.76
-78.22%
Total Debt
0.44
0.30
0.14
46.67%
Book Value per share (adjusted)
10.40
95.04
-84.64
-89.06%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






